Igenica Header
  | | | | |

 

Igenica Management
David V. Goeddel, Ph.D.
Executive Chairman
John K. Celebi, MBA Chief Business Officer
Guoqing Chen, Ph.D. VP of Research
Paul W. Sauer, MBA VP of Process Development
Igenica Management
David V. Goeddel, Ph.D.
Executive Chairman
John D. Diekman, Ph.D.
Carl L. Gordon, Ph.D., CFA
Robert Schreiber, Ph.D.
Igenica Management
Robert Schreiber, Ph.D.
Chairman
Rudolf Aebersold, Ph.D.  
Frederick Appelbaum, M.D.  
Thomas Kipps, M.D., Ph.D.  
Richard Klausner, M.D.  
Jeffrey V. Ravetch, M.D., Ph.D.  
Richard Ulevitch, Ph.D.  
Emil Unanue, M.D.  
 
 
 
 
Igenica Leadership

Dr. Klausner is the former Executive Director for Global Health of the Bill and Melinda Gates Foundation. He was the eleventh director of the National Cancer Institute between 1995 and 2001. His research has been recognized with awards including the Outstanding Investigator Award from the American Federation of Clinical Research and the William Damashek Prize for major discoveries in haematology. He received the 1997-1998 Dickson Prize in Medicine and the 1998 Raymond Bourgine Award. He has served as an Advisor to the Presidents of the Academies for counter-terrorism, and Liaison to the White House Office of Science & Technology Policy. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences. Dr. Klausner is a past president of the American Society of Clinical Investigation and has been Chairman of the National Science Education Standards Projects of the National Academy of Sciences.